BARTELS CYTOMEGALOVIRUS IMMED. EARLY ANTIGEN

Antisera, Conjugated Fluorescent, Cytomegalovirus

BAXTER HEALTHCARE CORP.

The following data is part of a premarket notification filed by Baxter Healthcare Corp. with the FDA for Bartels Cytomegalovirus Immed. Early Antigen.

Pre-market Notification Details

Device IDK904036
510k NumberK904036
Device Name:BARTELS CYTOMEGALOVIRUS IMMED. EARLY ANTIGEN
ClassificationAntisera, Conjugated Fluorescent, Cytomegalovirus
Applicant BAXTER HEALTHCARE CORP. P.O. BOX 3093 Bellevue,  WA  98009
ContactTom Trotter
CorrespondentTom Trotter
BAXTER HEALTHCARE CORP. P.O. BOX 3093 Bellevue,  WA  98009
Product CodeLIN  
CFR Regulation Number866.3175 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1990-09-05
Decision Date1990-10-16

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
05391516745901 K904036 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.